相关实验视频
Updated: Jan 13, 2026

06:13
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
24.3K
药物涂层气球和糖尿病:一篇综述
Marco Frazzetto1,2, Sara Malakouti1, Bharat Khialani1,3
1DCB Academy, Milan, Italy.
Cardiovascular diabetology
|October 28, 2025
概括
糖尿病复杂化冠状动脉疾病,通过皮肤冠状动脉干预后增加风险. 药物涂层气球为接受PCI的糖尿病患者提供了一个有希望的无支架替代方案,可能改善结果.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 生物医学工程 生物医学工程
背景情况:
- 糖尿病 (DM) 显著增加了冠状动脉疾病 (CAD) 的风险和严重程度.
- 糖尿病患者在皮肤冠状动脉干预 (PCI) 后面临的不良事件和支架相关并发症的风险高于非糖尿病患者.
- 尽管药物释放支架的进步,但糖尿病患者的长期结果仍然令人担忧.
研究的目的:
- 审查DM病理生理学对PCI结果的影响.
- 探索药物涂层气球 (DCB) 对糖尿病CAD患者的潜在益处.
- 总结当前证据,将DCB与其他PCI技术进行比较,并建议个性化治疗方法.
主要方法:
- 对DM,CAD,PCI和DCB技术研究的文献综述.
- 分析将DM与心血管不良事件联系起来的病理生理机制.
- 综合临床试验数据,比较DCB血管整形与糖尿病患者的其他重血管化策略.
主要成果:
- 脑膜炎与更复杂的动脉样硬化和前血栓,炎症状态有关,恶化PCI结果.
- 药物涂层的气球可以将抗增殖剂直接传递到病变上,而无需金属支架,从而提供潜在的优势.
- 在糖尿病人群中,将DCB与其他PCI技术进行比较的证据仍在不断发展,需要进一步研究.
结论:
- 对于患有CAD的糖尿病患者来说,DCB血管整形是一个有前途的治疗选择,可能会减轻与金属支架相关的风险.
- 需要进一步的研究,以充分阐明DCB在高风险人群中的长期疗效和最佳使用.
- 考虑DM特异性因素的个性化治疗策略对于优化糖尿病患者PCI结果至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
858
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
858
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Heart Failure Drugs: β-Blockers
758
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
758
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Heart Failure Drugs: Diuretics
789
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
789

